drugset / Trial / NCT00968045
Fibrinogen and Bleeding After Cardiac Surgery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The study hypothesis is that prophylactic fibrinogen infusion reduces postoperative bleeding and transfusion requirements after coronary artery bypass surgery (CABG) in patients with endogenous fibrinogen levels in the lower normal range. 60 patients will be included in a prospective, randomized double-blind placebo-controlled single center study.
Timeline
- Start
- 2009-04
- Primary completion
- 2012-02
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fibrinogen Concentrate Human | Protein / enzyme biologic | 2 g | — |